Relationship between elevated serum level of placental growth factor and status of gestational diabetes mellitus

References

• Higgins MF, Russell NE, Crossey PA, et al. Maternal and fetal placental growth hormone and IGF axis in type 1 diabetic pregnancy. PLoS One. 2012;7:e29164.
   PubMed Web of Science ®Google Scholar
• Saffer C, Olson G, Boggess KA, et al. Determination of placental growth factor (PlGF) levels in healthy pregnant women without signs or symptoms of preeclampsia. Pregnancy Hypertens. 2013;3:124–132.
   PubMed Web of Science ®Google Scholar
• Tsiakkas A, Duvdevani N, Wright A, et al. Serum placental growth factor in the three trimesters of pregnancy: effects of maternal characteristics and medical history. Ultrasound Obstet Gynecol. 2015;45:591–598.
   PubMed Web of Science ®Google Scholar
• Desoye G, Hartmann M, Jones CJP, et al. Location of insulin receptors in the placenta and its progenitor tissues. Microsc Res Tech. 1997;38:63–75.
   PubMed Web of Science ®Google Scholar
• Shore VH, Wang T-H, Wang C-L, et al. Vascular endothelial growth factor, placenta growth factor and their receptors in isolated human trophoblast. Placenta. 1997;18:657–665.
   PubMed Web of Science ®Google Scholar
• Vuorela P, Hatva E, Lymboussaki A, et al. Expression of vascular endothelial growth factor and placenta growth factor in human placenta. Biol Reprod. 1997;56:489–494.
   PubMed Web of Science ®Google Scholar
• Teede HJ, Harrison CL, Teh WT, et al. Gestational diabetes: development of an early risk prediction tool to facilitate opportunities for prevention. Aust N Z J Obstet Gynaecol. 2011;51:499–504.
   PubMed Web of Science ®Google Scholar
• Wier LM, Witt E, Burgess J, et al. Hospitalizations related to diabetes in pregnancy, 2008. HCUP Statistical Brief #102. Rockville (MD): Agency for Health Care Research and Quality; 2010.
   Google Scholar
• The American College of Obstetricians and Gynecologists (ACOG). Practice Bulletin. Gestational diabetes mellitus. Obstet Gynecol. 2013;122:406–416.
   PubMedGoogle Scholar
• Metzger BE, Buchanan TA, Coustan DR, et al. Summary and recommendations of the fifth international workshop-conference on gestational diabetes mellitus. Diabetes Care. 2007;30:S251–S260.
   PubMed Web of Science ®Google Scholar
• Nanda S, Nikoletakis G, Markova D, et al. Maternal serum retinol-binding protein-4 at 11–13 weeks’ gestation in normal and pathological pregnancies. Metabolism. 2013;62:814–819.
   PubMed Web of Science ®Google Scholar
• Nanda S, Poon LC, Muhaisen M, et al. Maternal serum resistin at 11 to 13 weeks’ gestation in normal and pathological pregnancies. Metabolism. 2012;61:699–705.
   PubMed Web of Science ®Google Scholar
• Ferreira AF, Rezende JC, Vaikousi E, et al. Maternal serum visfatin at 11–13 weeks of gestation in gestational diabetes mellitus. Clin Chem. 2011;57:609–613.
   PubMed Web of Science ®Google Scholar
• Lovati E, Beneventi F, Simonetta M, et al. Gestational diabetes mellitus: including serum pregnancy-associated plasma protein-A testing in the clinical management of primiparous women? A case–control study. Diabetes Res Clin Pract. 2013;100:340–347.
   PubMed Web of Science ®Google Scholar
• Riskin-Mashiah S, Younes G, Damti A, et al. First-trimester fasting hyperglycemia and adverse pregnancy outcomes. Diabetes Care. 2009;32:1639–1643.
   PubMed Web of Science ®Google Scholar
• Grewal E, Kansara S, Kachhawa G, et al. Prediction of gestational diabetes mellitus at 24 to 28 weeks of gestation by using first-trimester insulin sensitivity indices in Asian Indian subjects. Metabolism. 2012;61:715–720.
   PubMed Web of Science ®Google Scholar
• Levine RJ, Maynard SE, Qian C, et al. Circulating angiogenic factors and the risk of preeclampsia. N Engl J Med. 2004;350:672–683.
   PubMed Web of Science ®Google Scholar
• Akolekar R, Zaragoza E, Poon LC, et al. Maternal serum placental growth factor at 11 + 0 to 13 + 6 weeks of gestation in the prediction of pre-eclampsia. Ultrasound Obstet Gynecol. 2008;32:732–739.
   PubMed Web of Science ®Google Scholar
• Poon LC, Zaragoza E, Akolekar R, et al. Maternal serum placental growth factor (PlGF) in small for gestational age pregnancy at 11(+0) to 13(+6) weeks of gestation. Prenat Diagn. 2008;28:1110–1115.
   PubMed Web of Science ®Google Scholar
• Pandya P, Wright D, Syngelaki A, et al. Maternal serum placental growth factor in prospective screening for aneuploidies at 8–13 weeks’ gestation. Fetal Diagn Ther. 2012;31:87–93.
   PubMed Web of Science ®Google Scholar
• Ong CY, Lao TT, Spencer K, et al. Maternal serum level of placental growth factor in diabetic pregnancies. J Reprod Med. 2004;49:477–480.
   PubMed Web of Science ®Google Scholar
• Eleftheriades M, Papastefanou I, Lambrinoudaki I, et al. Elevated placental growth factor concentrations at 11–14 weeks of gestation to predict gestational diabetes mellitus. Metabolism. 2014;63:1419–1425.
   PubMed Web of Science ®Google Scholar
• Carpenter MW, Coustan DR. Criteria for screening tests for gestational diabetes. Am J Obstet Gynecol. 1982;144:768–773.
   PubMed Web of Science ®Google Scholar
• Mclntyre HD, Russell A, Serek R, et al. Placental growth hormone is not suppressed by oral glucose loading in normal human pregnancy. Horm Metab Res. 2002;34:250–253.
   PubMed Web of Science ®Google Scholar
• Verhaeghe J, Pintiaux A, Van Herck E, et al. Placental GH, IGF-I, IGF-binding protein-1, and leptin during a glucose challenge test in pregnant women: relation with maternal body weight, glucose tolerance, and birth weight. J Clin Endocrinol Metab. 2002;87:2875–2882.
   PubMed Web of Science ®Google Scholar
• Kazandi M, Hasdemir PS, Zeybek B, et al. Placental growth factor: a putative screening test for gestational diabetes mellitus in first trimester. Clin Exp Obstet Gynecol. 2010;37:322–323.
   PubMed Web of Science ®Google Scholar
• Cohen AL, Wenger JB, James-Todd T, et al. The association of circulating angiogenic factors and HbA1c with the risk of preeclampsia in women with preexisting diabetes. Hypertens Pregnancy. 2014;33:81–92.
   PubMed Web of Science ®Google Scholar
• Cvitic S, Desoye G, Hiden U. Glucose, insulin, and oxygen interplay in placental hypervascularisation in diabetes mellitus. BioMed Res Int. 2014;2014:1.
   Web of Science ®Google Scholar
• Geva E, Ginzinger DG, Zaloudek CJ, et al. Human placental vascular development: vasculogenic and angiogenic (branching and nonbranching) transformation is regulated by vascular endothelial growth factor-A, angiopoietin-1, and angiopoietin- 2. J Clin Endocrinol Metab. 2002;87:4213–4224.
   PubMed Web of Science ®Google Scholar
• Huynh J, Dawson D, Roberts D, et al. A systematic review of placental pathology in maternal diabetes mellitus. Placenta. 2015;36:101–114.
   PubMed Web of Science ®Google Scholar
• Lassance L, Miedl H, Absenger M, et al. Hyperinsulinemia stimulates angiogenesis of human fetoplacental endothelial cells: a possible role of insulin in placental hypervascularization in diabetes mellitus. J Clin Endocrinol Metab. 2013;98:E1438–E1447. Available from::e1438.
   PubMed Web of Science ®Google Scholar
• Chappell LC, Duckworth S, Seed PT, et al. Diagnostic accuracy of placental growth factor in women with suspected preeclampsia. Circulation. 2013;128:2121–2131.
   PubMed Web of Science ®Google Scholar
• Thadhani R, Hagmann H, Schaarschmidt W, et al. Removal of soluble fms-like tyrosine kinase-1 by dextran sulfate apheresis in preeclampsia. JASN. 2016;27:903–913.
   Web of Science ®Google Scholar
• Spradley FT, Tan AY, Joo WS, et al. Placental growth factor administration abolishes placental ischemia-induced hypertension. Hypertension. 2016;67:740–747.
   PubMed Web of Science ®Google Scholar
• Zhu M, Ren Z, Possomato-Vieira JS, et al. Restoring placental growth factor-soluble fms-like tyrosine kinase-1 balance reverses vascular hyper-reactivity and hypertension in pregnancy. Am J Physiol Regul Integr Comp Physiol. 2016;311:R505–R521.
   PubMed Web of Science ®Google Scholar
• Makris A, Yeung KR, Lim SM, et al. Placental growth factor reduces blood pressure in a uteroplacental ischemia model of preeclampsia in nonhuman primates. Hypertension. 2016;67:1263–1272.
   PubMed Web of Science ®Google Scholar
• Kumasawa K, Ikawa M, Kidoya H, et al. Pravastatin induces placental growth factor (PGF) and ameliorates preeclampsia in a mouse model. Proc Natl Acad Sci. 2011;108:1451–1455.
   PubMed Web of Science ®Google Scholar
• Pugh CW, Ratcliffe PJ. Regulation of angiogenesis by hypoxia: role of the HIF system. Nat Med. 2003;9:677–684.
   PubMed Web of Science ®Google Scholar
• Nelson SM, Coan PM, Burton GJ, et al. Placental structure in type 1 diabetes: relation to fetal insulin, leptin, and IGF-I. Diabetes. 2009;58(11):2634–2641
   PubMed Web of Science ®Google Scholar
• Jahan S, Ahmed CM, Zinnat R, et al. Influence of maternal diabetes on serum leptinemic and insulinemic status of the offspring: a case study of selected patients in a tertiary care hospital in Bangladesh. Diabetes Metab Syndr. 2011;5:33–37.
   PubMedGoogle Scholar
• Vela-Huerta MM, Amador-Licona N, Anaya-Aguirre S, et al. Insulin and leptin levels in appropriate-for-gestational-age infants of diabetic mother. Iran J Pediatr. 2012;22:475–480.
   PubMed Web of Science ®Google Scholar